文献速递炎症性肠病消化内镜

溃疡性结肠炎电子染色内镜评分PICaSSO的国际多中心真实世界前瞻研究

An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis.
PubMed 文献 · Gastroenterology · 2021-02-06

该国际多中心前瞻性研究纳入307例溃疡性结肠炎患者,用高清虚拟染色内镜评估直肠和乙状结肠的PICaSSO评分,并与MES、UCEIS及多个组织学指数对比。PICaSSO与组织学评分强相关且优于MES和UCEIS,PICaSSO≤3可识别组织学缓解并预测6和12个月结局。

要点

  • PICaSSO与组织学评分强相关,优于MES和UCEIS。
  • PICaSSO≤3识别RHI组织学缓解的AUROC为0.90。
  • PICaSSO≤3预测6和12个月较好结局,与组织学缓解相似。

核心结论

  • PICaSSO评分与多个组织学指数强相关,并可预测6和12个月特定临床结局,与组织学缓解相似,可作为UC治疗管理中有用的内镜工具。

研究设计与样本

  • 前瞻性国际多中心研究,共纳入307例溃疡性结肠炎患者,用高清和虚拟染色内镜评估直肠和乙状结肠的MES、UCEIS和PICaSSO,并进行靶向活检组织学评估。

主要发现

  • PICaSSO与组织学评分强相关,显著优于MES和UCEIS与组织学评分的相关系数。
  • PICaSSO≤3检测RHI组织学缓解(≤3且无中性粒细胞)的AUROC为0.90(95%CI 0.86-0.94),检测NHI≤1的AUROC为0.82(95%CI 0.77-0.87)。
  • PICaSSO的观察者间一致性为0.88(95%CI 0.83-0.92)。
  • 随访6和12个月时,PICaSSO≤3预测较好结局优于PICaSSO>3(HR分别为0.19[0.11-0.33]和0.22[0.13-0.34]),也优于PICaSSO 4-8(HR分别为0.25[0.12-0.53]和0.22[0.12-0.39]),与组织学缓解相似。

临床怎么用

  • PICaSSO可作为溃疡性结肠炎治疗管理中的内镜工具,用于评估疾病活动并预测6和12个月结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Endoscopic and histologic remission are important goals in the treatment of ulcerative colitis (UC). We investigated the correlation of the recently developed Paddington International Virtual ChromoendoScopy ScOre (PICaSSO) and other established endoscopic scores against multiple histological indices and prospectively assessed outcomes. METHODS: In this prospective multicenter international study, inflammatory activity was assessed with high-definition and virtual chromoendoscopy in the rectum and sigmoid using the Mayo Endoscopic Score (MES), UC Endoscopic Index of Severity (UCEIS), and PICaSSO. Targeted biopsies were taken for assessment using Robarts Histological Index (RHI), Nancy Histological index (NHI), ECAP (Extent, Chronicity, Activity, Plus score), Geboes, and Villanacci. Follow-up data were obtained at 6 and 12 months after colonoscopy. RESULTS: A total of 307 patients were recruited. There was strong correlation between PICaSSO and histology scores, significantly superior to correlation coefficients of MES and UCEIS with histology scores. A PICaSSO score of ≤3 detected histologic remission by RHI (≤3 + absence of neutrophils) with area under the receiver operating characteristic curve (AUROC) 0.90 (95% confidence interval [CI] 0.86-0.94) and NHI (≤1) AUROC 0.82 (95% CI 0.77-0.87). The interobserver agreement for PICaSSO was 0.88 (95% CI 0.83-0.92). At 6- and 12-months follow-up, PICaSSO score ≤3 predicted better outcomes than PICaSSO >3 (hazard ratio [HR] 0.19 [0.11-0.33] and 0.22 [0.13-0.34], respectively),} as well as PICaSSO 4-8 (HR 0.25 [0.12-0.53] and 0.22 (0.12-0.39), respectively) and similar to histologic remission. CONCLUSION: In this first real-life multicenter study, the PICaSSO score correlated strongly with multiple histological indices. Furthermore, PICaSSO score predicted specified clinical outcomes at 6 and 12 months, similar to histology. Thus, PICaSSO can be a useful endoscopic tool in the therapeutic management of UC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Iacucci M, Smith SCL, Bazarova A, et al. An International Multicenter Real-Life Prospective Study of Electronic Chromoendoscopy Score PICaSSO in Ulcerative Colitis. Gastroenterology. 2021. PMID: 33347880. doi:10.1053/j.gastro.2020.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。